Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were CNY 297.3 million, down 60.6% year over year, primarily due to a decrease in the number of medical service providers subscribing to information services [14] - Net loss attributable to So Young was CNY 33.1 million, compared to a net loss of CNY 21.2 million in the same period last year [17] - Non-GAAP net loss attributable to So Young was CNY 31.5 million, compared to non-GAAP net income of CNY 4.1 million during the same period in 2024 [17] - Basic and diluted losses per ADS were CNY 0.32, compared to CNY 0.21 in the same period of 2024 [18] - Cash and cash equivalents totaled CNY 1.1 billion as of March 31, 2025, indicating a robust cash position [18] Business Line Data and Key Metrics Changes - Revenue from aesthetic treatment services reached CNY 98.8 million, a remarkable 551.4% year over year increase, primarily due to the expansion of the aesthetic center business [15] - Total verified paid visits exceeded 45,500, up 18.5% quarter on quarter and 874.3% year over year [7] - Total number of verified paid aesthetic treatments performed surpassed 92,900, up 14% quarter on quarter and 989.4% year over year [7] - Cost of aesthetic treatment services was CNY 80.3 million, up 547.6% year over year, primarily due to the expansion of the aesthetic center business [16] Market Data and Key Metrics Changes - The aesthetic center business is gradually becoming the main growth driver, with 18 centers achieving positive monthly operating cash flow and 16 centers being profitable on a monthly basis as of March [6] - The company aims to build a differentiated nationwide light medical aesthetic chain with strong brand recognition [10] Company Strategy and Development Direction - The company is pursuing a vertical integration strategy and expanding its network of aesthetic centers in major cities [5] - A franchise model is being planned to accelerate geographic reach and network density while reducing capital expenditure pressure [32] - The company aims to develop proprietary products and control the supply chain, inspired by the Sam's Club retail model [11][19] - The focus is on high-quality proprietary products and services at fair prices, aiming to become a leading player in the medical aesthetics industry [12] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth potential of the aesthetic center business, emphasizing the importance of maintaining a sustainable financial model [32] - The company views trade tensions as an opportunity to strengthen its domestic supply chain and support import replacement [41] - The outlook for Q2 2025 expects aesthetic treatment services revenues to be between CNY 120 million and CNY 140 million, representing a 337.3% to 410.1% increase from the same period in 2024 [18][19] Other Important Information - The company has allocated additional marketing resources and implemented sales incentives to boost revenue contribution from proprietary products [9] - The number of institutions served with supply chain solutions for injectables grew to over 1,500 as of Q1 [9] Q&A Session Summary Question: How is So Young Clinic different from traditional medical institutions like Meilai and Istar? - The aesthetic center business uses a fast casual model, offering focused services with higher frequency and lower per customer spend compared to traditional models [23][24] Question: Will CapEx become a burden for the company as the clinic network grows? - The company emphasizes careful management of CapEx and plans to open around 30 new clinics per year while exploring a franchise model to reduce CapEx pressure [32][33] Question: How does the Miracle Laser create more synergy with the company's core business? - The integration of Wuhan Medical Laser improves R&D capabilities and supports the growth model by supplying high-quality, cost-effective equipment to aesthetic centers [35][36] Question: How will ongoing trade tensions impact the company's business? - The direct impact is limited, but the company sees it as an opportunity to strengthen its domestic supply chain and pivot to alternative products if necessary [41][43] Question: Can management elaborate on the company's future investment plan and cost reduction plan? - The company remains focused on sustainable growth, optimizing offerings, and increasing investment in proprietary product lines to support margin expansion [45][46]

科技筑基+系统赋能：破解临床痛点，激活长效增长 强强联手，共拓皮肤科价值增长新路径 针对医美光电项目高发的"反黑""敏感泛红""屏障脆弱"等临床难题，修芙缇依托国家级专利技术，与天津华中 进行专业联合推出"光针联合治疗修护方案"——修芙缇明星单品隐龄针配合水光、光电治疗，72小时持续激活 细胞自愈力，临床实测术后反黑率大幅降低，问题肌治疗效果翻倍，同时修芙缇基于"五维平衡"理念开发的术 后28天全维修护产品，从清洁-护肤-防护全维度管理，在日常护肤环节进行持续维养增效。 "光针联合治疗修护方案"通过联合"医美光电项目""专业院线护理"与"居家全维修护"，实现全层管理、分阶养 护帮助客户解决肌肤问题、修护细胞健康。天津华中院长张钰涵表示："我自己体验过修芙缇的产品以后现在 非常信任他们的产品力。我认为修芙缇的产品不是'锦上添花'，而是'雪中送炭'，以专业产品帮助我们完成了治 疗与修护的闭环，真正实现疗效与口碑双赢。" 在系统赋能层面，修芙缇"皮肤科良性增长系统"为天津华中注入全域增长动能：通过"品项运营系统"与院内光 电项目联合极大提升客户粘性，配合"效果管理系统"让客户认可疗效提升满意度，再通过"年度自销系统 ...

近年来，党中央、国务院部署实施了小规模纳税人税费优惠政策，助力经营主体发展壮大。然而，一些 不法分子却瞄准这些政策红利，通过拆分经营、隐匿收入、虚假纳税申报等手段骗享税费优惠，破坏公 平竞争的市场环境。近日，安徽、新疆、大连等地税务部门依法查处并曝光3起通过拆分经营骗享小规 模纳税人税费优惠偷税案件。 一是国家税务总局池州市税务局稽查局依法查处东至县荣峰再生资源回收站及盛荣峰骗享小规模纳税人 税费优惠偷税案件。经查，盛荣峰借用他人身份证设立85家回收站，通过将本该是荣峰再生资源回收站 的经营收入拆分至85家回收站，进行虚假纳税申报，违规享受小规模纳税人减免增值税政策，少缴增值 税、个人所得税等税费215.84万元。国家税务总局池州市税务局稽查局依据相关规定，依法对东至县荣 峰再生资源回收站及盛荣峰追缴税费款、加收滞纳金并处罚款，共计339.74万元。目前，涉案税费款、 滞纳金、罚款均已追缴入库。 二是国家税务总局阿拉尔税务局稽查局依法查处阿拉尔市宏润运输有限公司骗享小规模纳税人税费优惠 偷税案件。经查，阿拉尔市宏润运输有限公司系增值税一般纳税人，但其通过注册多家个体工商户拆分 经营，进行虚假纳税申报，违规享受 ...

AirSculpt (AIRS) Q1 2025 Earnings Call May 02, 2025 08:00 AM ET Company Participants Allison Malkin - PartnerYogi Jashnani - CEO & DirectorDennis Dean - CFOJoshua Raskin - Partner - Managed Care & ProvidersMorgan McCarthy - VP - Equity Research Conference Call Participants Sam Eiber - Vice President and Medical Technology AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - Beauty and Wellness Operator Greetings and welcome to the AirSculpt Technologies Inc. First Quarter twenty twen ...

AirSculpt (AIRS) Q1 2025 Earnings Call May 02, 2025 08:00 AM ET Company Participants Allison Malkin - PartnerYogi Jashnani - CEO & DirectorDennis Dean - CFOJoshua Raskin - Partner - Managed Care & ProvidersMorgan McCarthy - VP - Equity Research Conference Call Participants Sam Eiber - Vice President and Medical Technology AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - Beauty and Wellness Operator Greetings and welcome to the AirSculpt Technologies Inc. First Quarter twenty twen ...